Form 8-K - Current report:
SEC Accession No. 0001193125-25-044830
Filing Date
2025-03-04
Accepted
2025-03-04 07:05:24
Documents
15
Period of Report
2025-03-04
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d824505d8k.htm   iXBRL 8-K 35342
2 EX-99.1 d824505dex991.htm EX-99.1 16750
6 GRAPHIC g824505g0304094350239.jpg GRAPHIC 4788
  Complete submission text file 0001193125-25-044830.txt   194116

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA calc-20250304.xsd EX-101.SCH 2876
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE calc-20250304_lab.xml EX-101.LAB 18736
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE calc-20250304_pre.xml EX-101.PRE 11724
18 EXTRACTED XBRL INSTANCE DOCUMENT d824505d8k_htm.xml XML 3806
Mailing Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037
Business Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037 858-952-5500
CalciMedica, Inc. (Filer) CIK: 0001534133 (see all company filings)

EIN.: 452120079 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39538 | Film No.: 25701501
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)